Testing effectiveness (Phase 2)UnknownNCT04952493What this trial is testingAnlotinib or Penpulimab in Combination With RAI for DTCWho this might be right forThyroid Cancer Peking Union Medical College Hospital 42
Early research (Phase 1)Active Not RecruitingNCT05538130What this trial is testingLearn About the Study Medicine Called PF-07799544 as Monotherapy or in Combination in People With Advanced Solid TumorsWho this might be right forMelanomaGliomaThyroid Cancer+10 more Pfizer 148
Testing effectiveness (Phase 2)Study completedNCT00104871What this trial is testingBortezomib in Treating Patients With Metastatic Thyroid Cancer That Did Not Respond to Radioactive Iodine TherapyWho this might be right forInsular Thyroid CancerRecurrent Thyroid CancerStage II Follicular Thyroid Cancer+3 more National Cancer Institute (NCI) 24
Early research (Phase 1)Ended earlyNCT04234113What this trial is testingStudy of Nanrilkefusp Alfa Alone and With Pembrolizumab in Adult Patients With Advanced/Metastatic Solid TumorsWho this might be right forThyroid CancerRenal Cell CarcinomaNon Small Cell Lung Cancer+16 more SOTIO Biotech AG 115
Early research (Phase 1)Study completedNCT00667641What this trial is testingPaclitaxel and Bortezomib in Treating Patients With Metastatic or Unresectable Malignant Solid TumorsWho this might be right forBreast CancerColorectal CancerHead and Neck Cancer+6 more University of Medicine and Dentistry of New Jersey 16
Testing effectiveness (Phase 2)Study completedNCT00124527What this trial is testingStudy of Irofulven Plus Capecitabine in Patients With Advanced Thyroid CancerWho this might be right forThyroid Cancer Eisai Inc. 35
Not applicableApproved For MarketingNCT01683110What this trial is testingExpanded Access of Cabozantinib in Medullary Thyroid CancerWho this might be right forMedullary Thyroid Cancer Exelixis
Testing effectiveness (Phase 2)Ended earlyNCT00354523What this trial is testingImatinib in Combination With Dacarbazine and Capecitabine in Medullary Thyroid CarcinomaWho this might be right forSolid TumorThyroid Cancer M.D. Anderson Cancer Center 21
Not applicableStudy completedNCT01534897What this trial is testingRe-differentiation of Radioiodine-Refractory BRAF V600E-mutant Papillary Thyroid Carcinoma With GSK2118436Who this might be right forPapillary Thyroid Carcinoma Massachusetts General Hospital 10
Not applicableUnknownNCT04354324What this trial is testingTreatment Efficacy and Safety of Low-dose Radioiodine Ablation for Intermediate-risk Differentiated Thyroid CarcinomaWho this might be right forPapillary Thyroid Cancer Zhujiang Hospital 254
Early research (Phase 1)Study completedNCT00027534What this trial is testingVaccine Therapy in Treating Patients With Advanced or Metastatic CancerWho this might be right forBreast CancerColorectal CancerGallbladder Cancer+6 more Michael Morse, MD 14
Testing effectiveness (Phase 2)Looking for participantsNCT06923826What this trial is testingSacituzumab Govitecan in Metastatic Salivary Gland and Thyroid Cancers (SG-SGTC)Who this might be right forSalivary Gland CancerThyroid Cancer National University Hospital, Singapore 32
Testing effectiveness (Phase 2)Looking for participantsNCT05668962What this trial is testingRestor. I-131 Upt. + Selpercatinib in RET F-P RAI-R TCWho this might be right forThyroid CancerThyroid CarcinomaMetastatic Thyroid Cancer+3 more Massachusetts General Hospital 30
Not applicableNot Yet RecruitingNCT07299318What this trial is testingMultimodal Deep Learning for Lymph Node Metastasis in Thyroid CancerWho this might be right forPapillary Thyroid Carcinoma West China Hospital 3,200
Not applicableStudy completedNCT01624220What this trial is testingA Prospective Study Using Implanted Fiducial Markers to Assess Treatment Accuracy and Esophageal Toxicity in Spinal Stereotactic Body Radiation TherapyWho this might be right forSpinal Tumor M.D. Anderson Cancer Center 41
Early research (Phase 1)Ended earlyNCT03469011What this trial is testingTry to Bring Back Radioiodine Sensitivity in Patients With Advanced Thyroid Cancer.Who this might be right forPapillary Thyroid Cancer AHS Cancer Control Alberta 14
Not applicableLooking for participantsNCT06356272What this trial is testingOropharynx (OPX) Biomarker TrialWho this might be right forClinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Metastatic Oropharyngeal Squamous Cell Carcinoma+8 more Mayo Clinic 560
Testing effectiveness (Phase 2)Temporarily pausedNCT05453799What this trial is testingVudalimab for the Treatment of Locally Advanced or Metastatic Anaplastic Thyroid Cancer or Hurthle Cell Thyroid CancerWho this might be right forLocally Advanced Thyroid Gland Anaplastic CarcinomaMetastatic Thyroid Gland Anaplastic CarcinomaMetastatic Thyroid Gland Oncocytic Carcinoma Northwestern University 54
Testing effectiveness (Phase 2)Temporarily pausedNCT03139747What this trial is testingUPCC 36315 A Phase II Study Of Everolimus (RAD001) And Lenvatinib (E7080) In Patients With Metastatic Differentiated Thyroid Cancer Who Have Progressed on Lenvatinib AloneWho this might be right forThyroid Cancer Thomas Jefferson University 5
Testing effectiveness (Phase 2)Study completedNCT00098813What this trial is testingRomidepsin in Treating Patients With Recurrent and/or Metastatic Thyroid Cancer That Has Not Responded to Radioactive IodineWho this might be right forRecurrent Thyroid CancerStage IV Follicular Thyroid CancerStage IV Papillary Thyroid Cancer National Cancer Institute (NCI) 20